Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSS2400116	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products(3.3)	New Drug Application	2024-10-28		Hisun Biopharmaceutical Co Ltd			view
JYSB2300197	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products	Supplementary Application	2023-11-14					view
CXSS2300038	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products(3.3)	New Drug Application	2023-05-24		Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group			view
JYSZ2300019	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products	License Renew	2023-04-21					view
JYSB2300063	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products	Supplementary Application	2023-04-11					view
JYSB2300016	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products	Supplementary Application	2023-02-07					view
JYSB2300009	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products	Supplementary Application	2023-01-17					view
CXSS2300002	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products(3.3)	New Drug Application	2023-01-10		QILU Pharmaceutical Co Ltd			view
JXSS2200027	帕妥珠单抗曲妥珠单抗注射液（皮下注射）	pertuzumab;trastuzumab	Injection	Biological Products(3.1)	Import Drug Application	2022-07-27					view
JXSS2200026	帕妥珠单抗曲妥珠单抗注射液（皮下注射）	pertuzumab;trastuzumab	Injection	Biological Products(3.1)	Import Drug Application	2022-07-27					view
JYSB2200111	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products	Supplementary Application	2022-06-30					view
CXSL2101162	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products(3.3)	New Drug Application	2021-06-29		CSPC Megalith Biopharmaceutical Co Ltd			view
JYSB2101061	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products	Supplementary Application	2021-06-25					view
JYSB2101013	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products	Supplementary Application	2021-04-23					view
JYSB2000696	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products	Supplementary Application	2021-01-05	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Certificate Issued	2021-03-17	view
JYSB2000662	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products	Supplementary Application	2020-12-28	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	In Review	2020-12-24	view
JYSB2000601	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products	Supplementary Application	2020-12-07	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Filed	2020-12-17	view
JYSB2000387	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products	Supplementary Application	2020-08-21	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Certificate Issued	2020-10-15	view
JYSB2000386	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products	Supplementary Application	2020-08-21	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	Filed	2020-09-02	view
JYSB2000140	帕妥珠单抗注射液	pertuzumab	Injection	Biological Products	Supplementary Application	2020-05-06	罗氏（中国）投资有限公司	Roche (China) Holding Ltd	In Review	2020-05-01	view